Stericycle (NASDAQ: SRCL) is one of 20 publicly-traded companies in the “Waste Management, Disposal & Recycling Services” industry, but how does it weigh in compared to its rivals? We will compare Stericycle to related companies based on the strength of its analyst recommendations, earnings, risk, institutional ownership, profitability, dividends and valuation.
This table compares Stericycle and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
94.6% of Stericycle shares are held by institutional investors. Comparatively, 53.0% of shares of all “Waste Management, Disposal & Recycling Services” companies are held by institutional investors. 3.5% of Stericycle shares are held by company insiders. Comparatively, 12.3% of shares of all “Waste Management, Disposal & Recycling Services” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
This is a summary of recent ratings and recommmendations for Stericycle and its rivals, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Stericycle currently has a consensus target price of $75.90, suggesting a potential upside of 12.68%. As a group, “Waste Management, Disposal & Recycling Services” companies have a potential upside of 8.13%. Given Stericycle’s higher probable upside, equities research analysts clearly believe Stericycle is more favorable than its rivals.
Risk and Volatility
Stericycle has a beta of 0.16, meaning that its share price is 84% less volatile than the S&P 500. Comparatively, Stericycle’s rivals have a beta of 0.63, meaning that their average share price is 37% less volatile than the S&P 500.
Earnings and Valuation
This table compares Stericycle and its rivals top-line revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Stericycle||$3.56 billion||$206.35 million||-120.29|
|Stericycle Competitors||$850.65 million||$28.19 million||150.46|
Stericycle has higher revenue and earnings than its rivals. Stericycle is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Stericycle beats its rivals on 7 of the 13 factors compared.
Stericycle Company Profile
Stericycle, Inc. is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other. The Domestic and Canada RCS and International RCS segments include medical waste disposal, pharmaceutical waste disposal, hazardous waste management, sustainability solutions for expired or unused inventory, secure information destruction of documents and e-media, training and consulting through its Steri-Safe and Clinical Services programs, and other regulatory compliance services. The Domestic CRS segment consists of inbound/outbound communication, automated patient reminders, online scheduling, notifications, product retrievals, product returns and quality audits.
What are top analysts saying about Stericycle Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Stericycle Inc. and related companies.